Massachusetts Financial Services’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,494
Closed -$419K 910
2018
Q3
$419K Sell
6,494
-9,980
-61% -$557K ﹤0.01% 833
2018
Q2
$741K Sell
16,474
-33,359
-67% -$1.33M ﹤0.01% 795
2018
Q1
$1.55M Buy
49,833
+898
+2% +$29.5K ﹤0.01% 720
2017
Q4
$1.46M Buy
48,935
+6,754
+16% +$196K ﹤0.01% 722
2017
Q3
$1.39M Sell
42,181
-628
-1% -$21.8K ﹤0.01% 719
2017
Q2
$1.43M Buy
42,809
+1,232
+3% +$36.8K ﹤0.01% 731
2017
Q1
$1.2M Buy
41,577
+495
+1% +$12.3K ﹤0.01% 736
2016
Q4
$918K Sell
41,082
-2,470
-6% -$48.3K ﹤0.01% 771
2016
Q3
$809K Buy
43,552
+12,461
+40% +$235K ﹤0.01% 785
2016
Q2
$507K Buy
+31,091
New +$457K ﹤0.01% 791

Other funds holding BEAT

Massachusetts Financial Services's BEAT Position: Q4 2018 in Review

Massachusetts Financial Services sold out of BioTelemetry, Inc. (BEAT) in Q4 2018, closing a stake of 6,494 shares — an estimated $419K sold.

Massachusetts Financial Services first reported a position in BEAT in Q2 2016 and held it in 10 quarters. The position peaked at $1.55M in Q1 2018. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

  • Massachusetts Financial Services reported no remaining BioTelemetry, Inc. position as of Q4 2018 after selling out during the quarter.
  • Massachusetts Financial Services sold 6,494 BioTelemetry, Inc. shares in Q4 2018, an estimated $419K.
  • Massachusetts Financial Services first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 10 quarters.
  • Massachusetts Financial Services's BioTelemetry, Inc. position peaked at $1.55M in Q1 2018.
  • 281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on Massachusetts Financial Services's 13F filing for Q4 2018, filed 8 Feb 2019.